Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

SDS

Search for SDS (Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Academic Research Programs

Designed to meet all your research needs: Stocking Centers, New Lab Start-Up, Core Programs and access to special offers

Contact Us

Customer Service: 800-565-1400

Email Subscription Center

To receive the information that is relevant to your work, explore our subscription center and set your preferences

Corporate Responsibility

Learn more about our commitment to people, green chemistry and the environment

About Us

Our life science business features a portfolio of more than 300,000 products enabling scientific discovery.

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

News & Information

Burlington, Massachusetts - December 20, 2017 MilliporeSigma Collaborates with iCON™ to Offer BioReliance® End-to-End Turnkey Modular MAb Manufacturing Platform

MilliporeSigma today announced a collaboration with IPS-Integrated Project Services, LLC and G-CON Manufacturing, Inc. to provide the most advanced 2,000L monoclonal antibody (MAb) facility and single-use process technology platform.

Read More
Burlington, Massachusetts - December 20, 2017 MilliporeSigma Signs Commercial Supply Agreement with bluebird bio for Viral Vector Manufacturing

MilliporeSigma today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, for its use in potentially transformative gene therapies.

Read More
Burlington, Massachusetts - December 19, 2017 Singapore’s IP Office to Grant MilliporeSigma's Patent Application for CRISPR Technology

MilliporeSigma today announced that the Intellectual Property Office of Singapore has issued a “Notice of Eligibility for Grant” for MilliporeSigma’s patent application covering the company’s CRISPR technology.

Read More